ATRX and central nervous system cancer: In IDH1/2-mutant gliomas, elevated TERTp mutation rates predominantly reflected oligodendroglioma molecular profiles (with 1p/19q co-deletion), whereas astrocytoma subtypes were characterized by higher ATRX mutation rates.